2012

  • Invacare Corporation Announces Workforce Reduction at Taylor Street Manufacturing Facility in Elyria, Ohio
    12/27/12 9:18 am EST
    ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced that due to a decline in production, the Company has initiated an immediate workforce reduction at its Taylor Street manufacturing facility in Elyria, Ohio. The expected decline in production results principally from the Company’s previously announced consent decree of injunction with the United States Food and Drug Administration (FDA), which was approved late last week by the United Statesmore...
  • U.S. District Court Approves Invacare Corporation's Consent Decree with the FDA
    12/21/12 4:19 pm EST
    ELYRIA, Ohio--(BUSINESS WIRE)--Late this afternoon, Invacare Corporation (NYSE: IVC) learned that the United States District Court for the Northern District of Ohio, has approved the terms of the previously announced consent decree of injunction with the United States Food and Drug Administration (FDA). The consent decree relates to previously announced inspectional observations at the Company's corporate facility and its Taylor Street wheelchair manufacturing facility, bothmore...
  • Invacare Corporation to Sell Medical Supplies Business to AssuraMed
    12/21/12 8:00 am EST
    ELYRIA, Ohio & TWINSBURG, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) and AssuraMed announced today that they have signed a definitive agreement under which Invacare will sell Invacare Supply Group (ISG), its domestic medical supplies business, to AssuraMed for $150 million, subject to certain closing adjustments. This divestiture is consistent with Invacare's focus on its globalization strategy to harmonize core global product lines and reduce complexity within its business. Formore...
  • Invacare Corporation Reaches Agreement with FDA on Terms of Consent Decree, Subject to Approval of United States District Court
    12/20/12 4:15 pm EST
    ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced that it has reached an agreement on the terms of a consent decree of injunction with the United States Food and Drug Administration (FDA). The consent decree, which is subject to the approval of the United States District Court for the Northern District of Ohio, relates to previously announced inspectional observations at the Company's corporate facility and its Taylor Street wheelchairmore...
  • Invacare Corporation Reports Expected Impact of Medical Device Excise Tax Based on IRS Final Rule
    12/5/12 6:39 pm EST
    ELYRIA, Ohio--(BUSINESS WIRE)--The Internal Revenue Service today issued final regulations on the 2.3% excise tax on medical devices that is part of the Affordable Care Act. Invacare Corporation (NYSE: IVC) has reviewed the final regulations and believes that most of its products will be exempt from the tax based on the retail exemption provided in the regulations. Invacare believes that certain products that it sells for institutional use will be subject to the excise tax.more...
  • Invacare Declares Quarterly Dividend
    11/16/12 1:08 pm EST
    ELYRIA, Ohio--(BUSINESS WIRE)--The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable January 14, 2013 to shareholders of record on January 4, 2013. Invacare Corporation (NYSE:IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical productsmore...
  • Invacare Corporation Announces Financial Results for the Third Quarter and First Nine Months of 2012
    10/25/12 6:30 am EDT
    ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced its financial results for the quarter and nine months ended September 30, 2012. CEO SUMMARY Commenting on Invacare's third quarter 2012 results, Gerald B. Blouch, President and Chief Executive Officer, stated, ''The Company's first priority continues to be focused on making improvements to its quality systems related to previously disclosed observations made by the Unitedmore...
  • Invacare Corporation to Host Conference Call to Discuss Third Quarter 2012 Results
    10/16/12 8:00 am EDT
    ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC) (“Invacare” or the “Company”) announces that it will release its financial results for the third quarter 2012 before the market opens on Thursday, October 25, 2012. The Company will sponsor a conference call for investors and other interested parties on Thursday, October 25, 2012 at 8:30 AM EDT to discuss the Company’s performance. Those wishing to participate in the live call should dial 1-888-498more...
  • Invacare Chief Executive Officer, Gerald B. Blouch, Presenting at Morgan Stanley and CL King & Associates Conferences in September
    8/28/12 9:06 am EDT
    ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced its conference schedule for September: On Wednesday, September 12, at 11:30 a.m., Gerald B. Blouch, president and chief executive officer, will present at the Morgan Stanley 2012 Global Healthcare Conference at the Grand Hyatt in New York. The audio webcast of the presentation will be available at http://cc.talkpoint.com/morg007/091112a_mc/?entity=82_86D121Imore...
  • Invacare Declares Quarterly Dividend
    8/14/12 2:57 pm EDT
    ELYRIA, Ohio--(BUSINESS WIRE)--The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable October 12, 2012 to shareholders of record on October 4, 2012. Invacare Corporation (NYSE:IVC - news), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term caremore...

Business Wire NewsHQ℠